| Literature DB >> 27303727 |
Christopher J Harmer1, Ruth M Hall1.
Abstract
The IS26 transposase, Tnp26, catalyzes IS26 movement to a new site and deletion or inversion of adjacent DNA via a replicative route. The intramolecular deletion reaction produces a circular molecule consisting of a DNA segment and a single IS26, which we call a translocatable unit or TU. Recently, Tnp26 was shown to catalyze an additional intermolecular, conservative reaction between two preexisting copies of IS26 in different plasmids. Here, we have investigated the relative contributions of homologous recombination and Tnp26-catalyzed reactions to the generation of a transposon from a TU. Circular TUs containing the aphA1a kanamycin and neomycin resistance gene or the tet(D) tetracycline resistance determinant were generated in vitro and transformed into Escherichia coli recA cells carrying R388::IS26. The TU incorporated next to the IS26 in R388::IS26 forms a transposon with the insertion sequence (IS) in direct orientation. Introduction of a second TU produced regions containing both the aphA1a gene and the tet(D) determinant in either order but with only three copies of IS26. The integration reaction, which required a preexisting IS26, was precise and conservative and was 50-fold more efficient when both IS26 copies could produce an active Tnp26. When both ISs were inactivated by a frameshift in tnp26, TU incorporation was not detected in E. coli recA cells, but it did occur in E. coli recA (+) cells. However, the Tnp-catalyzed reaction was 100-fold more efficient than RecA-dependent homologous recombination. The ability of Tnp26 to function in either a replicative or conservative mode is likely to explain the prominence of IS26-bounded transposons in the resistance regions found in Gram-negative bacteria. IMPORTANCE In Gram-negative bacteria, IS26 recruits antibiotic resistance genes into the mobile gene pool by forming transposons carrying many different resistance genes. In addition to replicative transposition, IS26 was recently shown to use a novel conservative movement mechanism in which an incoming IS26 targets a preexisting one. Here, we have demonstrated how IS26-bounded class I transposons can be produced from translocatable units (TUs) containing only an IS26 and a resistance gene via the conservative reaction. TUs were incorporated next to an existing IS26, creating a class I transposon, and if the targeted IS26 is in a transposon, the product resembles two transposons sharing a central IS26, a configuration observed in some resistance regions and when a transposon is tandemly duplicated. Though homologous recombination could also incorporate a TU, Tnp26 is far more efficient. This provides insight into how IS26 builds transposons and brings additional transposons into resistance regions.Entities:
Keywords: IS26; translocatable unit; transposition; transposons
Year: 2016 PMID: 27303727 PMCID: PMC4894685 DOI: 10.1128/mSphere.00038-16
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
FIG 1 Building IS26-bounded transposons. (A) Schematic of a typical IS26-bounded class I transposon. IS26 (green box) and the 14-bp inverted repeats of IS26 (open triangles) are indicated. An arrow indicates the position and orientation of tnp26. The extent of the compound transposon and two alternate translocatable units (TUs) are shown above and below the schematic representation. (B) Two pathways to IS26-mediated formation of compound transposons. The relative frequency of the Tnp26-mediated and RecA-dependent reactions is indicated by the size of the label. Eight-base-pair direct repeats of the target sequence are indicated by a flag.
FIG 2 Formation of complex antibiotic resistance regions. (A) Structure of Tn6026. (B) Building transposons using TUs derived from Tn4352 and Tntet(D). The origin of each IS26-bounded structure is shown above. Genes and open reading frames are shown as arrows indicating the direction of transcription. Genes conferring antibiotic resistance are black. IS26 elements are shown as open boxes with an arrow indicating the position and orientation of tnp26.
Frequency of TU incorporation in a recA background
| TU | Plasmid in UB1637 | No. of transformants/µg of TU | |
|---|---|---|---|
| Values for individual experiments | Avg value | ||
| TU | R388::IS | 166, 153, 142, 162 | 156 |
| R388 | 0, 0, 0 | 0 | |
| TU | R388::IS | 7, 9, 5 | 7 |
| R388 | 0, 0, 0 | 0 | |
| R388::Tn | 5, 11, 12 | 9 | |
| TU | R388::Tn | 148, 176, 161 | 162 |
Kmr Tpr transformants for TU4352 or TU4352B transformed into cells containing R388::IS26, Tcr Tpr transformants for TUtet(D) transformed into cells containing R388::IS26, Kmr Tcr Tpr for TU4352 or TU4352B transformed into cells containing R388:TUtet(D) and for TUtet(D) transformed into cells containing R388::Tn4352.
Four experiments were performed for TUaphA1a and UB1637-R388::IS26, and three experiments were performed for all other combinations of TU and plasmid.
Transformation of recA+ and recA mutant strains carrying R388::IS26
| TU | Plasmid in UB1637 | Expt no. or | No. of Kmr Tpr transformants/µg | |
|---|---|---|---|---|
| UB1637 ( | E294 ( | |||
| TU | R388::IS | 1 | 100 | 195 |
| 2 | 272 | 126 | ||
| 3 | 153 | 181 | ||
| Avg | 175 | 167.3 | ||
| TU | R388::IS | 1 | 1 | 2 |
| 2 | 2 | 0 | ||
| 3 | 0 | 0 | ||
| 4 | 1 | 2 | ||
| Avg | 1 | 1 | ||
| TU | R388::IS | 1 | 2 | 1 |
| 2 | 2 | 2 | ||
| 3 | 1 | 0 | ||
| 4 | 1 | 2 | ||
| Avg | 1.5 | 1.3 | ||
| TU | R388::IS | 1 | 0 | 1 |
| 2 | 0 | 2 | ||
| 3 | 0 | 1 | ||
| 4 | 0 | 2 | ||
| 5 | 0 | 0 | ||
| Avg | 0 | 1.5 | ||
IS26-FS-L, frameshift mutation in tnp26 in the TU, producing a truncated 30-aa protein.
IS26-FS-R, frameshift mutation in R388::IS26 tnp26.
Plasmids used in this study
| Plasmid | Description | Resistance | Reference |
|---|---|---|---|
| pRMH761 | 8.8-kb BamHI fragment of pRMH760 | Ap Km Nm | |
| pRMH976 | pRMH761 derivative containing Tn | Ap Km Nm | |
| pRMH990 | pRMH761 derivative with frameshifts | Ap Km Nm | |
| R388::IS | R388 with IS | Su Tp | |
| R388::IS | R388::IS | Su Tp | |
| R388::Tn | R388 containing Tn | Km Nm Su Tp | |
| R388::Tn | R388 containing Tn | Km Nm Su Tp | |
| p39R861-4 | Type 2 A/C2 plasmid carrying Tn | Cm Fl Su Tc | |
| pUC19::Tn | 6.0-kb SacI fragment of p39R861-4 | Ap Tc | This |
Ap, ampicillin; Cm, chloramphenicol; Fl, florfenicol; Km, kanamycin; Nm, neomycin; Su, sulfamethoxazole; Tc, tetracycline; Tp, trimethoprim.
1.8-kb central SwaI Tn4352B fragment replaced with Tn4352 from pDGO100.
Frameshift generated by end filling the BsiWI site and duplicating 116 to 119 bp from the left end of IS26 as shown in Fig. 5 of Harmer et al. (5).
IS26 8-bp duplication of bases 26745 to 26752 in R388 (GenBank accession no. BR000038).
Lacks 13 bp (bases 624 to 636 from the left end of IS26).
Tn4352B together with 8-bp duplication of bases 26745 to 26752 in R388 (GenBank accession number BR000038).
Bases 134454 to 140495 from p39R861-4 cloned into pUC19.